Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-10, Vol.29, p.viii370-viii370 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | viii370 |
|---|---|
| container_issue | |
| container_start_page | viii370 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Jandial, A. HJ, S. Mishra, K. Bhadada, S. Sood, A. Prakash, M. Meshram, A. Sandal, R. Lad, D. Aggarwal, R. Prakash, G. Vikas, S. Khadwal, A.R. Kumari, S. Varma, N. Varma, S.C. Malhotra, P. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy286.034 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy286_034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419494970</els_id><sourcerecordid>32136902</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2304-f3d4f81a96fa82c215cba433402b034bc48993e1a5607ebd007049331e07e82f3</originalsourceid><addsrcrecordid>eNp9kF9LwzAUxYMobk4_gC-SL9At_9o1-CTin8HAF301pOkti7ZJSbpBv70ZnT76cLlcOOdw7g-hW0qWlEi-0s55Z1ZdPbKyWBIuztCc5oXMSiLoOZoTyXi2zrmYoasYvwghhWTyEs04o7yQhM3R56brtRmwb3BlY7_zx3F6AKxdnWawWTdC6zuNhx0E3Y_YO1x5B3jYB-cPEHCnwzeEiK3D3b4dbN8CPpmu0UWj2wg3p71AH89P74-v2fbtZfP4sM0M40RkDa9FU1Iti0aXzDCam0oLzgVhVXqrMqKUkgPVeUHWUNWErImQnFNIZ8kavkB0yjXBxxigUX2wqdeoKFFHVmpipSZWKoUmz93k6fdVB_Wf4xdOEtxPAkjNDxaCisaCM1DbAGZQtbf_xP8AqJR9hw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Jandial, A. ; HJ, S. ; Mishra, K. ; Bhadada, S. ; Sood, A. ; Prakash, M. ; Meshram, A. ; Sandal, R. ; Lad, D. ; Aggarwal, R. ; Prakash, G. ; Vikas, S. ; Khadwal, A.R. ; Kumari, S. ; Varma, N. ; Varma, S.C. ; Malhotra, P.</creator><creatorcontrib>Jandial, A. ; HJ, S. ; Mishra, K. ; Bhadada, S. ; Sood, A. ; Prakash, M. ; Meshram, A. ; Sandal, R. ; Lad, D. ; Aggarwal, R. ; Prakash, G. ; Vikas, S. ; Khadwal, A.R. ; Kumari, S. ; Varma, N. ; Varma, S.C. ; Malhotra, P.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy286.034</identifier><identifier>PMID: 32136902</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii370-viii370</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32136902$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jandial, A.</creatorcontrib><creatorcontrib>HJ, S.</creatorcontrib><creatorcontrib>Mishra, K.</creatorcontrib><creatorcontrib>Bhadada, S.</creatorcontrib><creatorcontrib>Sood, A.</creatorcontrib><creatorcontrib>Prakash, M.</creatorcontrib><creatorcontrib>Meshram, A.</creatorcontrib><creatorcontrib>Sandal, R.</creatorcontrib><creatorcontrib>Lad, D.</creatorcontrib><creatorcontrib>Aggarwal, R.</creatorcontrib><creatorcontrib>Prakash, G.</creatorcontrib><creatorcontrib>Vikas, S.</creatorcontrib><creatorcontrib>Khadwal, A.R.</creatorcontrib><creatorcontrib>Kumari, S.</creatorcontrib><creatorcontrib>Varma, N.</creatorcontrib><creatorcontrib>Varma, S.C.</creatorcontrib><creatorcontrib>Malhotra, P.</creatorcontrib><title>Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kF9LwzAUxYMobk4_gC-SL9At_9o1-CTin8HAF301pOkti7ZJSbpBv70ZnT76cLlcOOdw7g-hW0qWlEi-0s55Z1ZdPbKyWBIuztCc5oXMSiLoOZoTyXi2zrmYoasYvwghhWTyEs04o7yQhM3R56brtRmwb3BlY7_zx3F6AKxdnWawWTdC6zuNhx0E3Y_YO1x5B3jYB-cPEHCnwzeEiK3D3b4dbN8CPpmu0UWj2wg3p71AH89P74-v2fbtZfP4sM0M40RkDa9FU1Iti0aXzDCam0oLzgVhVXqrMqKUkgPVeUHWUNWErImQnFNIZ8kavkB0yjXBxxigUX2wqdeoKFFHVmpipSZWKoUmz93k6fdVB_Wf4xdOEtxPAkjNDxaCisaCM1DbAGZQtbf_xP8AqJR9hw</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Jandial, A.</creator><creator>HJ, S.</creator><creator>Mishra, K.</creator><creator>Bhadada, S.</creator><creator>Sood, A.</creator><creator>Prakash, M.</creator><creator>Meshram, A.</creator><creator>Sandal, R.</creator><creator>Lad, D.</creator><creator>Aggarwal, R.</creator><creator>Prakash, G.</creator><creator>Vikas, S.</creator><creator>Khadwal, A.R.</creator><creator>Kumari, S.</creator><creator>Varma, N.</creator><creator>Varma, S.C.</creator><creator>Malhotra, P.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma</title><author>Jandial, A. ; HJ, S. ; Mishra, K. ; Bhadada, S. ; Sood, A. ; Prakash, M. ; Meshram, A. ; Sandal, R. ; Lad, D. ; Aggarwal, R. ; Prakash, G. ; Vikas, S. ; Khadwal, A.R. ; Kumari, S. ; Varma, N. ; Varma, S.C. ; Malhotra, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2304-f3d4f81a96fa82c215cba433402b034bc48993e1a5607ebd007049331e07e82f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jandial, A.</creatorcontrib><creatorcontrib>HJ, S.</creatorcontrib><creatorcontrib>Mishra, K.</creatorcontrib><creatorcontrib>Bhadada, S.</creatorcontrib><creatorcontrib>Sood, A.</creatorcontrib><creatorcontrib>Prakash, M.</creatorcontrib><creatorcontrib>Meshram, A.</creatorcontrib><creatorcontrib>Sandal, R.</creatorcontrib><creatorcontrib>Lad, D.</creatorcontrib><creatorcontrib>Aggarwal, R.</creatorcontrib><creatorcontrib>Prakash, G.</creatorcontrib><creatorcontrib>Vikas, S.</creatorcontrib><creatorcontrib>Khadwal, A.R.</creatorcontrib><creatorcontrib>Kumari, S.</creatorcontrib><creatorcontrib>Varma, N.</creatorcontrib><creatorcontrib>Varma, S.C.</creatorcontrib><creatorcontrib>Malhotra, P.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jandial, A.</au><au>HJ, S.</au><au>Mishra, K.</au><au>Bhadada, S.</au><au>Sood, A.</au><au>Prakash, M.</au><au>Meshram, A.</au><au>Sandal, R.</au><au>Lad, D.</au><au>Aggarwal, R.</au><au>Prakash, G.</au><au>Vikas, S.</au><au>Khadwal, A.R.</au><au>Kumari, S.</au><au>Varma, N.</au><au>Varma, S.C.</au><au>Malhotra, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii370</spage><epage>viii370</epage><pages>viii370-viii370</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32136902</pmid><doi>10.1093/annonc/mdy286.034</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-10, Vol.29, p.viii370-viii370 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy286_034 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A56%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20bisphosphonate%20and%20anti-myeloma%20therapy%20on%20bone%20turnover%20markers%20in%20multiple%20myeloma&rft.jtitle=Annals%20of%20oncology&rft.au=Jandial,%20A.&rft.date=2018-10&rft.volume=29&rft.spage=viii370&rft.epage=viii370&rft.pages=viii370-viii370&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy286.034&rft_dat=%3Cpubmed_cross%3E32136902%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32136902&rft_els_id=S0923753419494970&rfr_iscdi=true |